1. Van Ermengem E. A new anaerobic bacillus and its relation to botulism. Rev Infect Dis. 1979:701-19. [ DOI:10.1093/clinids/1.4.701] 2. Pickett A. On the discovery of Bacillus botulinus. The Botulinum Journal. 2008;1(1):5-6. [ DOI:10.1504/TBJ.2008.018957] 3. Johnson EA, Bradshaw M. Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective. Toxicon. 2001;39(11):1703-22. [ DOI:10.1016/S0041-0101(01)00157-X] [ PMID] 4. Valipour E, Moosavi ML, Amani J, Nazarian S. High level expression, purification and immunogenicity analysis of a protective recombinant protein against botulinum neurotoxin type E. World J Microbiol Biotechnol. 2014;30(6), 1861-1867. [ DOI:10.1007/s11274-014-1609-0] [ PMID] 5. Pourshafie M, Saifie M, Shafiee A, Vahdani P, Aslani M, Salemian J. An outbreak of food-borne botulism associated with contaminated locally-made cheese in Iran. Scand J Infect Dis. 1998;30(1):92-4. [ DOI:10.1080/003655498750002385] [ PMID] 6. Baghban R, Gargari SL, Rajabibazl M, Nazarian S, Bakherad H. Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris. Biotechnol Appl Biochem. 2016;63(2):200-5. [ DOI:10.1002/bab.1226] [ PMID] 7. Hatheway CL. Clostridium botulinum and other clostridia that produce botulinum neurotoxin. In Clostridium botulinum. 2018; 2-20. [ DOI:10.1201/9781315139623-1] 8. Goonetilleke A, Harris J. Clostridial neurotoxins. J Neurol, Neurosurg Psychiatry. 2004;75. [ DOI:10.1136/jnnp.2004.046102] [ PMID] [ ] 9. Dolly J, Aoki K. The structure and mode of action of different botulinum toxins. Eur J Paediatr Neurol. 2006;13:1-9. [ DOI:10.1111/j.1468-1331.2006.01648.x] [ PMID] 10. Heymann DL. Control of communicable diseases manual. Am J Public Health. 2008;19. [ DOI:10.1071/NB08016] [ PMID] 11. McCarty CL, Angelo K, Beer KD, Cibulskas-White K, Quinn K, de Fijter S, et al. Large outbreak of botulism associated with a church potluck meal-Ohio. Morb Mortal Wkl Rep. 2015;64(29):802. [ DOI:10.15585/mmwr.mm6429a6] [ PMID] [ ] 12. Ehrt S, Schnappinger D. Isolation of plasmids from E. coli by alkaline lysis. E coli Plasmid Vectors. Springer; 2003. p. 75-8. [ DOI:10.1385/1-59259-409-3:75] [ PMID] 13. Fairweather NF, Lyness VA, Maskell DJ. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli. Infect Immun. 1987;55(11):2541-5. [ DOI:10.1128/iai.55.11.2541-2545.1987] [ PMID] [ ] 14. Smith LA. Development of recombinant vaccines for botulinum neurotoxin. Toxicon. 1998;36(11):1539-48. [ DOI:10.1016/S0041-0101(98)00146-9] [ PMID] 15. Rusnak JM, Smith LA. Botulinum neurotoxin vaccines: Past history and recent developments. Hum Vaccines. 2009;5(12):794-805. [ DOI:10.4161/hv.9420] [ PMID] 16. Baldwin MR, Tepp WH, Przedpelski A, Pier CL, Bradshaw M, Johnson EA, et al. Subunit vaccine against the seven serotypes of botulism. Infect Immun. 2008;76(3):1314-8. [ DOI:10.1128/IAI.01025-07] [ PMID] [ ] 17. Dolimbek BZ, Steward LE, Aoki KR, Atassi MZ. Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin. Mol Immunol. 2008;45(4):910-24. [ DOI:10.1016/j.molimm.2007.08.007] [ PMID] 18. Rostami H, Moosavi SJ, Ebrahimi F, Hajizadeh A. Cloning and Expression of the Catalytic Domain of Botulinum Neurotoxin Type E in E. coli. J. Mazandaran Univ Med Sci. 2013;22(97):148-57. 19. Baradaran M, Ebrahimi F, Nazarian S, Hajizade A, Tarverdizadeh Y. Subcloning and Assessment of the Expression of Synthetic Botulinum Neurotoxin Type B Binding Domain (BD/B). J Qom Univ Med Sci. 2016;10(5), 29-37. 20. Sharma S, Zhou Y, Singh BR. Cloning, expression, and purification of C-terminal quarter of the heavy chain of botulinum neurotoxin type A. Protein Expression Purif. 2006;45(2):288-95. [ DOI:10.1016/j.pep.2005.07.020] [ PMID] 21. Clayton MA, Clayton JM, Brown DR, Middlebrook JL. Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli. Infect Immun. 1995;63(7):2738-42. [ DOI:10.1128/iai.63.7.2738-2742.1995] [ PMID] [ ] 22. Zhou Y, Singh BR. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain. Protein Expression Purif. 2004;34(1):8-16. [ DOI:10.1016/j.pep.2003.10.015] [ PMID] |
